Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry.
Xu P, Xing X, Yu K, Lv Z, Cui H, Shi Y, Chang T, Zhang D, Zhang Y, Wang K, Lu J, Huang Q, Li X, Cui Y, Shi L, Wang T, Niu J, Wang J. Xu P, et al. Among authors: lv z. Emerg Microbes Infect. 2020 Dec;9(1):1695-1701. doi: 10.1080/22221751.2020.1791736. Emerg Microbes Infect. 2020. PMID: 32615862 Free PMC article. Review.
The prevention of stroke by statins: A meta-analysis.
San X, Lv Z, Xu P, Wang J, Lan T. San X, et al. Among authors: lv z. Medicine (Baltimore). 2022 Sep 23;101(38):e30606. doi: 10.1097/MD.0000000000030606. Medicine (Baltimore). 2022. PMID: 36197216 Free PMC article.
Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques.
Zhang Y, Chang T, Lu Q, Cui Y, Zhang D, Wang B, Xu P, Lu J, Ma J, Lv Z, Wang J. Zhang Y, et al. Among authors: lv z. Evid Based Complement Alternat Med. 2022 Oct 3;2022:7416448. doi: 10.1155/2022/7416448. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36225188 Free PMC article.
Comparative the efficacy and acceptability of immunosuppressive agents for myasthenia gravis: A protocol for systematic review and network meta-analysis.
Xu P, Zhang Y, Chang T, Jiang L, Lv Z, Zhang Y, Xu H, Zhang D, Lan T, Cui Y, Hua Z, Gao C, Lu J, Huang Q, Tian J, Ma J, Wang J. Xu P, et al. Among authors: lv z. Medicine (Baltimore). 2022 Dec 16;101(50):e31454. doi: 10.1097/MD.0000000000031454. Medicine (Baltimore). 2022. PMID: 36550882 Free PMC article.
Short-term outcome prediction for myasthenia gravis: an explainable machine learning model.
Zhong H, Ruan Z, Yan C, Lv Z, Zheng X, Goh LY, Xi J, Song J, Luo L, Chu L, Tan S, Zhang C, Bu B, Da Y, Duan R, Yang H, Luo S, Chang T, Zhao C; Pan-Yangtze River Delta Alliance for Neuromuscular Disorders (PYDAN). Zhong H, et al. Among authors: lv z. Ther Adv Neurol Disord. 2023 Feb 24;16:17562864231154976. doi: 10.1177/17562864231154976. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 36860354 Free PMC article.
4,471 results